Keywords: فارماکوژنتیک; Pharmacogenomics; Pharmacogenetics; Pharmacokinetic; Pharmacodynamics; P-glycoprotein; Adenosine-triphosphate binding cassette (ABC);
مقالات ISI فارماکوژنتیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فارماکوژنتیک; Cancer; Personalized medicine; Tumour microenvironment; Immunobiology; Targeted therapy; Pharmacogenetics; SmPC (alias SPC); summary of product characteristics; IBD; inflammatory bowel disease; ADCC; antibody-dependent cell-mediated cytotoxicity; CDC; com
Keywords: فارماکوژنتیک; Simulation; Pharmacogenetics; Standardized patient; Counseling; Curriculum;
Keywords: فارماکوژنتیک; Medicina personalizada; Laboratorio clÃnico; Genómica; Farmacogenética; Personalised medicine; Laboratory medicine; Genomics; Pharmacogenetics;
Keywords: فارماکوژنتیک; MDD; major depressive disorder; GAD; generalized anxiety disorder; QIDS-SR; Quick Inventory of Depressive Symptoms; Q-LES-Q-SF; Quality of Life Enjoyment and Satisfaction Questionnaire Short Form; UKU; Udvalg for Kliniske Undersøgelser Side Effect Rating
Keywords: فارماکوژنتیک; Drug metabolizing enzymes; ontogeny; paediatric pharmacology; pharmacodynamics; pharmacogenetics; pharmacokinetics;
Keywords: فارماکوژنتیک; l-Methylfolate; Methylenetetrahydrofolate reductase; MTHFR; Depression; Pharmacogenetics;
Keywords: فارماکوژنتیک; Warfarin; INR; Pharmacogenetics; Antibiotics; Vitamin K;
Keywords: فارماکوژنتیک; Liver transplantation; Immunosuppression; Biomarker monitoring; Personalization; Pharmacogenetics;
Keywords: فارماکوژنتیک; Tardive dyskinesia; Pharmacogenetics; Schizophrenia; Disrupted-In-Schizophrenia-1 (DISC1);
Keywords: فارماکوژنتیک; ABC; ATP-binding cassette; AHUI; aqueous humor uptake index; AUC; area under the curve; BAB; blood-aqueous barrier; BBB; blood-brain barrier; BCRP; breast cancer resistance protein; BRB; blood-retinal barrier; BUI; brain uptake index; MATE1; multidrug and
Keywords: فارماکوژنتیک; Tardive dyskinesia (TD); Pharmacogenetics; Pathophysiology; Dopamine D2 receptor gene (DRD2); Dopamine D3 receptor gene (DRD3); Vesicular monoamine transporter 2 gene (VMAT2/SLC18A2); Heparan sulfate proteoglycan 2 (HSPG2); Manganese superoxide dismutase
Keywords: فارماکوژنتیک; Pharmacogenetics; Pharmacogenetic test; Antidepressant; Efficacy; Personalized medicine;
Keywords: فارماکوژنتیک; Toxicity; Efficacy; Pharmacokinetics; Pharmacogenetics; Modeling; Immunotherapy; Adherence;
Keywords: فارماکوژنتیک; Mood stabilizers; Bipolar disorder; Pharmacogenetics; Epigenetics;
Keywords: فارماکوژنتیک; Visit-to-visit variability; Lipoprotein; GWAS; Pharmacogenetics; Risk factor; Vascular disease;
Keywords: فارماکوژنتیک; Genetic; Depression; CYP450; Pharmacodynamics; Pharmacokinetics; Antidepressant; Pharmacogenetics; Pharmacogenomics; Cost-effectiveness; Genesight; CNSDose;
Keywords: فارماکوژنتیک; Pharmacogenetics; Depression; Anxiety; Efficacy; Treatment response; Precision medicine;
Keywords: فارماکوژنتیک; Cognition; GABAergic inhibition; Pharmacogenetics; Prefrontal cortex; PVIs; Synaptic function; Thalamus;
Keywords: فارماکوژنتیک; Schizophrenia; Antipsychotics; Endogenous dopamine; Indirect agonism; Dopamine D2 receptors; Pharmacogenetics; Therapeutic variability; Treatment efficacy and failure;
Keywords: فارماکوژنتیک; Pharmacogenetics; Colorectal cancer; Polymorphism; Toxicity; Implementation;
Keywords: فارماکوژنتیک; Electroconvulsive therapy; Loxapine; Neuroleptic malignant syndrome; Pharmacokinetics; Pharmacogenetics; Phenoconversion; Sismothérapie; Loxapine; Syndrome malin des neuroleptiques; Pharmacocinétique; Pharmacogénétique; Phénoconversion;
Keywords: فارماکوژنتیک; Opioids; Interactions; Pharmacogenetics; Cytochrome P450; P-glycoprotein; OPRM1;
Keywords: فارماکوژنتیک; Endothelial nitric oxide synthase; Genetic polymorphisms; Haplotypes; Nitric oxide; NOS3 gene; Pharmacogenetics;
Keywords: فارماکوژنتیک; Steroid response; asthma; fluticasone; genome-wide association studies; inhaled corticosteroids; pharmacogenetics; 1000G; 1000 Genomes Project; FF; Fluticasone furoate; FP; Fluticasone propionate; GWAS; Genome-wide association study; ICS; Inhaled corticos
Keywords: فارماکوژنتیک; Dichloroacetate; Pyruvate dehydrogenase kinase; GSTZ1; Pharmacogenetics; Pharmacokinetics; Inhibition of metabolism;
Keywords: فارماکوژنتیک; Severe asthma; Mepolizumab; Pharmacogenetics; Exacerbation;
Keywords: فارماکوژنتیک; Symptom control; hospice/palliative care; pharmacological treatment; investigational agents; pharmacogenetics;
Keywords: فارماکوژنتیک; Methotrexate; Genetic polymorphisms; Pharmacogenetics; Acute lymphoblastic leukemia; Non-Hodgkin lymphoma;
Keywords: فارماکوژنتیک; Warfarin; Pharmacogenetics; Pharmacometrics; Dosing nomogram; Precision medicine;
Keywords: فارماکوژنتیک; ABC; avidin-biotin complex; AD; anterodorsal thalamic nucleus; AM; anteromedial thalamic nucleus; AV; anteroventral thalamic nucleus; DREADD; designer receptors exclusively activated by designer drugs; EGTA; ethylene glycol-bis(β-aminoethyl ether)-N,N,
Keywords: فارماکوژنتیک; Pharmacogenetics; Precision medicine; Informatics; Clinical decision support; Systematized nomenclature of medicine;
Keywords: فارماکوژنتیک; Chemotherapy; Neurotoxicity; Oxaliplatin; Pharmacogenetics; Taxane; Vincristine;
Keywords: فارماکوژنتیک; Adrenocorticotropic hormone; Child abuse; Clinical trial; Dexamethasone; Pharmacogenetics;
Keywords: فارماکوژنتیک; Drug efficacy; drug safety; individual variability; personalized medicine; pharmacodynamics; pharmacogenetics; pharmacogenomics; pharmacokinetics; precision medicine; stratified medicine
Keywords: فارماکوژنتیک; Essais cliniques; Cerveau virtuel; Pharmacoépidémiologie; Pharmacologie quantitative des systèmes; Pharmacogenétique; Clinical trials; Virtual brain; Pharmacoepidemiology; Quantitative system pharmacologie; Pharmacogenetics;
Keywords: فارماکوژنتیک; Pharmacogenetics; Pharmacovigilance; Adverse drug reactions; UGT1A1; TPMT; DPYD; CYP2D6; VKORC1/CYP2C9; CYP2C19; HLA;
Keywords: فارماکوژنتیک; Alcohol addiction; Genetics; Mu opioid receptor; Pharmacogenetics;
Keywords: فارماکوژنتیک; NDM; neonatal diabetes mellitus; PNDM; permanent neonatal diabetes mellitus; TNDM; transient neonatal diabetes mellitus; UPD6; paternal isodisomy of chromosome 6; Genetics; Neonatal diabetes mellitus; Personalized Medicine; Pharmacogenetics;
Keywords: فارماکوژنتیک; Raloxifene; Negative symptoms; Schizophrenia; Genetics; Pharmacogenetics; Postmenopause;
Keywords: فارماکوژنتیک; discrete choice experiment; patients' preferences; pharmacogenetics; willingness to pay;
Keywords: فارماکوژنتیک; Brain imaging technology; Health information technology; Pharmacogenetics; Telepsychiatry; Computer based psychiatric interventions;
Keywords: فارماکوژنتیک; Capecitabine; 5-Fluorouracil; DPYD; Dihydropyrimidine dehydrogenase; Fluoropyrimidines; Toxicity; Personalized medicine; Pharmacogenetics
Keywords: فارماکوژنتیک; Methotrexate; Rheumatoid arthritis; Polymorphism; Pharmacogenetics; Metotrexato; Artritis reumatoide; Polimorfismo; Farmacogenética;
Keywords: فارماکوژنتیک; Nocebo; Adverse effects; Adverse event; Pharmacogenetics; Iatrogenic; Drug safety; Drug tolerability;
Keywords: فارماکوژنتیک; Pharmacogenetics; Pharmacogenomics; Cancer; Resistance; Somatic mutations
Keywords: فارماکوژنتیک; Clopidogrel; Physiology-directed population pharmacokinetic and pharmacodynamic model; Pharmacogenetics; CYP2C19; CES1; PK/PD modeling
Keywords: فارماکوژنتیک; Bipolar disorder; Genetics; GWAS; Sequencing; Copy number variation (CNV); Family study; Personalized medicine; Pharmacogenetics;
Keywords: فارماکوژنتیک; Statins; Myopathy; Coenzyme Q10; Pharmacogenetics; Physiogenomics; Myalgia; Lipid metabolism; PCSK9 inhibitors;
Keywords: فارماکوژنتیک; Statin; Adverse effects; Drug-drug interactions; Pharmacogenetics; ABC; ATP-binding cassette; ASCVD; atherosclerotic cardiovascular disease; CPIC; Clinical Pharmacogenetic Implementation Consortium; CK; creatinine kinase; CV; cardiovascular; CVD; cardio